2 Fantastic Growth Stocks to Buy Hand Over Fist
It's a lot easier to convince yourself to buy a stock when it's flying high than when it's in the doldrums. You can see the momentum and imagine it continuing. But when a stock is stagnating or falling -- as long as the company has solid long-term prospects -- those are actually the best times to get in on the story. So take a second look at the market's recent laggards -- some may offer great buying opportunities.
That's the case for gene-editing specialist CRISPR Therapeutics (NASDAQ: CRSP) and e-commerce niche player (NASDAQ: ETSY). Both offer fantastic growth prospects -- yet their shares today aren't reflecting this potential.
CRISPR Therapeutics shares have declined 80% from the high point they reached back in 2021, and this year, they're little changed. At the same time, the company is heading toward its biggest moment yet. The Food and Drug Administration (FDA) is set to decide whether to approve what would be the biotech's first commercialized product.
Source Fool.com
